Irritable Bowel Syndrome Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 70 years old who have been diagnosed with Irritable Bowel Syndrome (IBS) based on recognised medical guidelines (Rome IV or V criteria)
- People whose belly pain scores above a certain level, as measured by a standard questionnaire called PROMIS (a score above 12)
Who may not be able to join:
- People who have another significant digestive or gut condition at the same time, such as coeliac disease or inflammatory bowel disease (IBD)
- People who have another serious ongoing illness or abnormal test results that the trial doctors consider risky or that could affect the study results
- People who have had major gut surgery in the past, such as bowel removal or a gastric bypass type procedure
- People with a Body Mass Index (BMI) above 30 (confirm with trial site for how this is measured)
- People who have had an active cancer diagnosis in the last 5 years, not including a type of minor skin cancer called basal cell cancer
- People who are currently pregnant or breastfeeding
- People who are currently in another clinical trial, or who have been in one within the past month
- People who have used antibiotics or probiotics during the study period or within one month before it starts
- People who have started a new medication less than 4 weeks before the study begins
- People who have allergies to any ingredients used in the study (confirm with trial site for full ingredient list)
- People who have a condition that weakens the immune system
- People who are currently receiving treatment for an eating disorder, schizophrenia, psychosis, or another acute mental health condition
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Dorsal Root Ganglion (DRG) neuron rheobase by chemostat supernatant; Change in Dorsal Root Ganglion (DRG) neuron rheobase by fecal supernatant
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.